TABLE OF CONTENT: 1. Introduction 1. Research Scope 2. Market Segmentation 3. Research Methodology 4. Definitions and Assumptions 2. Executive Summary 3. Market Dynamics 1. Market Drivers 2. Market Restraints 3. Market Opportunities 4. Key Insights 1. Pipeline Analysis 2. New Product Launches 3. Statistics of Opioid Use Disorder 4. Industry Developments Such as Mergers, Acquisitions, and Collaborations 5. Global Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis, Insights and Forecast – By Drug Class 1. Buprenorphine 2. Methadone 3. Naltrexone 3. Market Analysis, Insights and Forecast – By Route of Administration 1. Oral 2. Parenteral 4. Market Analysis, Insights and Forecast – By Distribution Channel 1. Hospitals Pharmacies 2. Retail Pharmacies & Stores 3. Online Pharmacies 5. Market Analysis, Insights and Forecast – By Region 1. North America 2. Europe 3. Asia Pacific 4. Rest of the World 6. North America Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Drug Class 1. Buprenorphine 2. Methadone 3. Naltrexone 3. Market Analysis – By Route of Administration 1. Oral 2. Parenteral 4. Market Analysis – By Distribution Channel 1. Hospitals Pharmacies 2. Retail Pharmacies & Stores 3. Online Pharmacies 5. Market Analysis – By Country 1. U.S. 2. Canada 7. Europe Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Drug Class 1. Buprenorphine 2. Methadone 3. Naltrexone 3. Market Analysis – By Route of Administration 1. Oral 2. Parenteral 4. Market Analysis – By Distribution Channel 1. Hospitals Pharmacies 2. Retail Pharmacies & Stores 3. Online Pharmacies 5. Market Analysis – By Country/ sub-region 1. U.K. 2. Germany 3. France 4. Spain 5. Italy 6. Scandinavia 7. Rest of Europe 8. Asia Pacific Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Drug Class 1. Buprenorphine 2. Methadone 3. Naltrexone 3. Market Analysis – By Route of Administration 1. Oral 2. Parenteral 4. Market Analysis – By Distribution Channel 1. Hospitals Pharmacies 2. Retail Pharmacies & Stores 3. Online Pharmacies 5. Market Analysis – By Country 1. Japan 2. China 3. India 4. Australia 5. Southeast Asia 6. Rest of Asia Pacific 9. Rest of the World Opioid Use Disorder (OUD) Market Analysis, Insights and Forecast, 2015-2026 1. Key Findings / Summary 2. Market Analysis – By Drug Class 1. Buprenorphine 2. Methadone 3. Naltrexone 3. Market Analysis – By Route of Administration 1. Oral 2. Parenteral 4. Market Analysis – By Distribution Channel 1. Hospitals Pharmacies 2. Retail Pharmacies & Stores 3. Online Pharmacies 10. Competitive Analysis 1. Key Industry Developments 2. Global Market Share Analysis (2017) 3. Competition Dashboard 4. Comparative Analysis – Major Players 5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability)) 1. Indivior PLC 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 2. Alkermes 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 3. Orexo US, Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 4. Titan Pharmaceuticals Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 5. TEVA PHARMACEUTICALS USA, INC 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 6. Mallinckrodt 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 7. BioDelivery Sciences International Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 8. Mylan 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 9. Pfizer Inc. 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 10. Hikma Pharmaceuticals 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 11. Camurus 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 12. Other Prominent Players 1. Overview, 2. Products & services, 3. SWOT analysis, 4. Recent developments, 5. strategies, 6. financials (based on availability) 11. Strategic Recommendations

Indivior PLC Alkermes Orexo US, Inc. Titan Pharmaceuticals Inc. TEVA PHARMACEUTICALS USA, INC Mallinckrodt. BioDelivery Sciences International Inc. Mylan Pfizer Inc. Hikma Pharmaceuticals Camurus